Pharmstandard International S.A. 13F Holdings · last filed Q3 2018
Pharmstandard International S.A. reported 6 securities worth $29.04M in its SEC 13F filing for Q3 2018 (period ended 2018-09-30). Top holdings: ALNAQ (32.28%), PTGX (26.59%), NTGN (17.31%). Among its top 25 positions this quarter: 1 new, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ALNAQ | Allena Pharmaceuticals | $9.4M | 32.28% | 873,031 | Trimmed |
| 2 | PTGX | Protagonist Therapeutics, Inc. | $7.7M | 26.59% | 750,632 | Hold |
| 3 | NTGN | Neon Therapeutics Inc. | $5.0M | 17.31% | 588,611 | New |
| 4 | JNCE | Jounce Therapeutics, Inc. | $3.7M | 12.65% | 565,063 | Hold |
| 5 | TARA | Proteon Therapeutics Inc. | $3.1M | 10.79% | 1.6M | Hold |
| 6 | ARGSQ | Argos Therapeutics Inc. | $109,000 | 0.38% | 1.1M | Hold |
Source: SEC Form 13F filings · as of 2018-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR